Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Revenue

Cardiff Oncology had revenue of $109.00K in the quarter ending March 31, 2025, a decrease of -46.83%. This brings the company's revenue in the last twelve months to $587.00K, down -3.77% year-over-year. In the year 2024, Cardiff Oncology had annual revenue of $683.00K with 39.96% growth.

• Revenue (ttm): $587.00K
• Revenue Growth: -3.77%
• P/S Ratio: 273.25
• Revenue / Employee: $17,788
• Employees: 33
• Market Cap: 209.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	683.00K	195.00K	39.96%
Dec 31, 2023	488.00K	102.00K	26.42%
Dec 31, 2022	386.00K	27.00K	7.52%
Dec 31, 2021	359.00K	-7.00K	-1.91%
Dec 31, 2020	366.00K	121.37K	49.61%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.